I met a former investment banker once. He told me that the greatest asset is time, and it is important to hold long positions to make money. This is by far the best way to invest, and in unstable markets, I will be usually riding everything out, but sometimes, I will be buying stocks/ETF's etc that I will only be holding for short term, so I can still make money when the market is rough. 

 

 

​​Here's my current portfolio and some updates:​​

​

Right now, I am trying to diversify (spread out) my investments. I will be using a formula I created to analyze stocks, and I will be selecting the strongest stock or stocks from each financial sector (section of the economy) to invest in. I will then spread out the money evenly across each stock (except for the risker ones--I'll invest less in those). My investments sector by sector are below. I will reevaluate my investments in every sector after every earnings report. 

​

Also, it's important to know that these picks are mostly based off of how undervalued the stocks are, but as of now, I'm not investing in very much because stock just released their 3rd quarter earnings, so I'm researching while taking their new earnings into account. 

​

​​​​​

​

​

Health Care:

Other than the riskier pick of Beam Therapeutics (see below), I also bought some Bristol Myers Squibb (BMY) stock. It is a well-established pharmaceutical company that makes a variety of medicines, and its shares are trading way below where it should be. I bought it at $43.60 a share on 10/13/25.

​

​

​​​​​

​

​

Riskier stocks:

 

I'm not following my usual investing strategy with these stock picks. These are stocks that may have some good long term potential but may not be the best according to my formula as of now. 

​

As a riskier pick, I am investing in BEAM Therapeutics (BEAM). CRISPR gene editing technology looks like it will play a huge role in the future of healthcare, and BEAM is able to edit individual letters in DNA, putting them ahead of a lot of their competitors that are working on CRISPR. I bought it at $25.48 a share on 10/7/25. As of 11/7, the stock is down quite a bit, but I am still holding it because I bought the stock to hold it for a whole. 

​

​

​

​

Here are my past trades using my newest strategy:

​

1. I bought NVIDIA (NVDA) on 10/22/25 at $177.40 a share. NVIDIA shares (and the whole market) was down quite a bit that day, and I thought that it would be a great time to buy NVIDIA ahead of its Washington DC conference from 10/27-10/29 where they would announce a lot of their new technology. This was a very good short-term buy, and I ended up selling my shares at $210.24 the morning of 10/29.​

​

​

2. I invested in First Solar (FSLR) as a stock in the energy sector. According to a bunch of my research, solar power is one of the best energy sources for the future, so I decided to buy a solar power stock. Out of 10 of the largest solar power companies I analyzed, First Solar was the best stock to buy according to my formula. I bought it on 8/26/25 at $196.71 a share. I sold it on 11/05/25 at $269.78 a share, which is a 37% gain. 

 

3.  I invested in Vale (VALE) as a stock in the materials sector. Vale is a company based in South America, and it mines metals. Vale has super high earnings per share (the company's profits divided across each of the shares) considering how low its share price is. This is shown through the really low P/E (price to earnings) ratio, which is used to show how overvalued or undervalued a stock is, and Vale is undervalued. I bought it on 8/26/25 at $10.18 a share. I sold it on 11/05/25 at $12.14 a share, which is a 19% gain. 

​

4. I invested in UPS (UPS) as a stock in the industrials sector. UPS delivers packages, and just like Vale, it has really high earnings per share for its stock price. I bought UPS on 8/26/25 at $87.40, and I sold it on 11/05/25 at $92.31, which is about a 5.5% gain. 

​

5. I bought some Bristol Myers Squibb (BMY) stock. It is a well-established pharmaceutical company that makes a variety of medicines, and its shares are trading way below where it should be. I bought it at $43.60 a share on 10/13/25, and I sold it on 11/05/25 at $45.97 a share, which is about a 5.5% gain. ​​​​

​